BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157 Ligament: 1 Unsafe Truth RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion